Statistics for Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation
Total visits
views | |
---|---|
Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation | 39 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 1 |
December 2024 | 0 |
January 2025 | 2 |
February 2025 | 0 |
File Visits
views | |
---|---|
Shueb_umn_0130E_23594.pdf | 53 |
Top country views
views | |
---|---|
United States | 15 |
United Kingdom | 4 |
Taiwan | 3 |
Canada | 2 |
Ireland | 2 |
Switzerland | 1 |
China | 1 |
Germany | 1 |
Egypt | 1 |
Hong Kong SAR China | 1 |
Indonesia | 1 |
India | 1 |
Japan | 1 |
Netherlands | 1 |
Russia | 1 |
Turkey | 1 |
Ukraine | 1 |
Top city views
views | |
---|---|
Chicago | 2 |
Dublin | 2 |
Minneapolis | 2 |
Amsterdam | 1 |
Ankara | 1 |
Ashburn | 1 |
Blacksburg | 1 |
Camberley | 1 |
Central | 1 |
Chang-hua | 1 |
Chaska | 1 |
Daettlikon | 1 |
Ipswich | 1 |
Jakarta | 1 |
Knoxville | 1 |
London | 1 |
Ludhiana | 1 |
Mountain View | 1 |
Rothenbach an der Pegnitz | 1 |
St Louis | 1 |
Taichung | 1 |
Valley Stream | 1 |
Vladivostok | 1 |
Windsor | 1 |